TECNOTREE
10.6.2022 13:47:07 CEST | Business Wire | Press release
Tecnotree, a Finland-based global provider of digital transformation solutions for Digital Service Providers (DSPs), today announced that it has been selected as ‘MongoDB Independent Software Vendor (ISV) Partner of the Year - Telco’ winner in the annual MongoDB World event at New York.
Padma Ravichander, CEO Tecnotree, said “We are proud to receive this award from MongoDB for helping our customers transition to new technologies and build digital ecosystems. Our technology platform allows customers to quickly deploy new services in response to market demand. Tecnotree’s digital BSS suite 5 provides end-to-end digital transformation for our enterprise customers, creating new efficiencies along the value chains. We are honoured to have this partnership with MongoDB. As we prepare for another exciting year ahead, we will continue to work closely with them to build custom-tailored solutions for our consumers.”
‘The MongoDB Partner of the Year Awards’ honour projects and people that thrive to help MongoDB telecom customers with their journey to the cloud. They celebrate the ground-breaking use of data to build compelling applications, modernize legacy ones, and the creativity of professionals expanding the limits of technology with MongoDB. This year partners were selected based on MongoDB end customer impact and influence.
Tecnotree was selected based on its unique set of offerings in the form of Cloud management, mobility and IoT, enterprise application development, software maintenance, and real-time offerings for enhanced customer experience, with their complete range of BSS Suite products and services. Tecnotree is addressing its goals towards building digital ecosystems by providing enterprises with a variety of solutions that help them with their digital transformation journey, using MongoDB as the underlying technology.
“At MongoDB, our partners are critical to our ability to care for our customers. The last two years have been a remarkably challenging time, with widespread changes affecting the entire world—and certainly the IT industry—like never before. However, this time has also brought customers and partners together to solve common problems,” said Alan Chhabra, Executive Vice President of Worldwide Partners, MongoDB. “At MongoDB, we’re committed to helping our customers evolve to this next stage of necessary innovation and are so grateful to all our partners who help make it happen. We’re cheering on this year's winners to carry on this competition’s legacy of honouring game-changing ideas, and I look forward to seeing the influence they make on the industry and the future.”
About Tecnotree
Tecnotree is the full-stack digital business management solution provider for digital service providers, with over 40 years of deep domain knowledge, proven delivery, and transformation capability across the globe. Our open-source technology-based agile products comprise the full range (order-to-cash) of business process and subscription management for telecom and DSPs with a pre-integrated B2B2X partner ecosystem across gaming, health, education, OTT, etc. Tecnotree products, platforms, and partners support emerging ecosystems of over 1 Billion subscribers across 70+ countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220610005241/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom